Literature DB >> 32818653

miR-421 up-regulation by the oleanolic acid derivative K73-03 regulates epigenetically SPINK1 transcription in pancreatic cancer cells leading to metabolic changes and enhanced apoptosis.

Abdullah Shopit1, Xiaodong Li2, Zhongyuan Tang3, Mohammed Awsh1, Loubna Shobet4, Mengyue Niu1, Hongyan Wang1, Haithm Mousa5, Mohammed Alshwmi5, Tsehaye Tesfaldet1, Yaser Gamallat6, Hailong Li1, Peng Chu1, Nisar Ahmad1, Yazeed Jamalat1, Jie Ai1, Eskandar Qaed1, Marwan Almoiliqy1, Shisheng Wang7, Zeyao Tang8.   

Abstract

SPINK1 overexpression promotes cancer cell aggressiveness and confers chemo-resistance to multiple drugs in pancreatic cancer. Oleanolic acid (OA) derivatives possess active effects against different cancers. Here we report the effect of K73-03, a new novel OA derivative, against pancreatic cancer through mitochondrial dysfunction via miR-421/SPINK1 regulation. We examined the binding ability of miR-421 with SPINK1-3'UTR Luciferase reporter assays. Moreover, miR-421/SPINK1 expressions in pancreatic cancer, with or without K73-03 treatment, were evaluated. Cells viability, migration, autophagy, mitochondrial function and apoptosis were examined with or without K73-03 treatment. We established that the K73-03 effect on the miR-421 that plays a crucial role in the regulation of SPINK1 in pancreatic cancer. Our findings indicated that K73-03 inhibited the mitochondrial function that led to inducing autophagy and apoptosis through epigenetic SPINK1 down-regulation via miR-421 up-regulation in pancreatic cancer. Furthermore, the inhibition of miR-421 expression in pancreatic cancer cells abolished the efficacy of K73-03 against SPINK1 oncogenic properties. We found an interesting finding that the interaction between miR-421 and SPINK1 is related to mitochondrial function through the effect of K73-03. Further, SPINK1 appear to be the molecular targets of K73-03 especially more than gemcitabine.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Gemcitabine; Gemcitabine (PubChem CID: 60749); K73-03; Oleanolic acid; Oleanolic acid (PubChem CID: 10494); Pancreatic cancer; SPINK1; miR-421

Mesh:

Substances:

Year:  2020        PMID: 32818653     DOI: 10.1016/j.phrs.2020.105130

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  6 in total

Review 1.  Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review.

Authors:  Tomas Koltai; Stephan Joel Reshkin; Tiago M A Carvalho; Daria Di Molfetta; Maria Raffaella Greco; Khalid Omer Alfarouk; Rosa Angela Cardone
Journal:  Cancers (Basel)       Date:  2022-05-18       Impact factor: 6.575

2.  Inhibition of miR-421 Preserves Mitochondrial Function and Protects against Parkinson's Disease Pathogenesis via Pink1/Parkin-Dependent Mitophagy.

Authors:  Xiaolin Dong; Xianghua He; Li Yang; Qingyun Li; Yanming Xu
Journal:  Dis Markers       Date:  2022-05-10       Impact factor: 3.464

3.  CircSEC24A (hsa_circ_0003528) interference suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells via miR-421/MMP3 axis.

Authors:  Bo Zhang; Jian Zhou
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

Review 4.  SPINKs in Tumors: Potential Therapeutic Targets.

Authors:  Chengcheng Liao; Qian Wang; Jiaxing An; Minglin Zhang; Jie Chen; Xiaolan Li; Linlin Xiao; Jiajia Wang; Qian Long; Jianguo Liu; Xiaoyan Guan
Journal:  Front Oncol       Date:  2022-02-11       Impact factor: 6.244

5.  Downregulated lncRNA SNHG18 Suppresses the Progression of Hepatitis B Virus-Associated Hepatocellular Carcinoma and Meditates the Antitumor Effect of Oleanolic Acid.

Authors:  Wenqi Song; Xuemei Zhang; Lin Feng; Yongwei Lai; Tongtong Li; Pengxia Zhang
Journal:  Cancer Manag Res       Date:  2022-02-18       Impact factor: 3.989

6.  Identification of Six N7-Methylguanosine-Related miRNA Signatures to Predict the Overall Survival and Immune Landscape of Triple-Negative Breast Cancer through In Silico Analysis.

Authors:  Jing Xu; Xiaoxia Cen; Yu Yao; Suo Zhao; Wei Li; Wei Zhang; Ming Qiu
Journal:  J Oncol       Date:  2022-09-26       Impact factor: 4.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.